Bionexus Gene Lab Corp (BGLC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 1,233 | 1,338 | 2,383 | 1,153 | 814 |
| Marketable Securities | 2,289 | 2,627 | 1,656 | 1,742 | 2,245 |
| Receivables | 186 | 231 | 649 | 1,725 | 2,105 |
| Inventories | 653 | 667 | 677 | 1,007 | 1,216 |
| Other current assets | 583 | 333 | 83 | 0 | 0 |
| TOTAL | $4,943 | $5,196 | $5,449 | $5,627 | $6,379 |
| Non-Current Assets | |||||
| PPE Net | 1,538 | 1,577 | 1,599 | 1,571 | 1,593 |
| Investments And Advances | 2,027 | 2,029 | 2,028 | 238 | 1,249 |
| Other Non-Current Assets | 219 | 238 | 178 | 186 | 200 |
| TOTAL | $3,783 | $3,844 | $3,804 | $1,994 | $3,042 |
| Total Assets | $8,726 | $9,040 | $9,253 | $7,621 | $9,421 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 616 | 592 | 404 | 375 | 1,675 |
| Other current liabilities | 125 | 130 | 50 | 50 | 16 |
| TOTAL | $813 | $797 | $521 | $678 | $1,758 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 89 | 104 | 117 | 127 | 141 |
| TOTAL | $135 | $150 | $117 | $127 | $141 |
| Total Liabilities | $948 | $947 | $638 | $805 | $1,899 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 2,933 | 2,417 | 2,417 | 1,797 | 1,797 |
| Common Shares | 20,175 | 20,175 | 20,175 | 17,332 | 17,332 |
| Retained earnings | -7,257 | -6,971 | -6,427 | -5,391 | -4,682 |
| Other shareholders' equity | -127 | -99 | -121 | -113 | -116 |
| TOTAL | $7,778 | $8,093 | $8,615 | $6,816 | $7,522 |
| Total Liabilities And Equity | $8,726 | $9,040 | $9,253 | $7,621 | $9,421 |